applicable) •Complications •Nursing Management
Gout
Chapter 34, page 1089
Chapter 20, page 418 Chapter 20, page 418
Epidemiology Chapter 34, page 1089
Pathophysiology and Clinical Manifestations Interprofessional Management •Medical Management •Surgical Management (when applicable) •Complications •Nursing Management
Chapter 34, page 1089
Chapter 20, page 418
Chapter 34, page 1090
Chapter 20, page 419
Fibromyalgia
Chapter 34, page 1091
Chapter 20, page 420 Chapter 20, page 420
Epidemiology Chapter 34, page 1091
Pathophysiology and Clinical Manifestations Interprofessional Management •Medical Management •Surgical Management (when applicable) •Complications •Nursing Management
Chapter 34, page 1091
Chapter 20, page 421
Chapter 34, page 1091
Chapter 20, page 421
Chapter 21: Coordinating Care for Patients With Multidrug-Resistant Organism Infectious Disorders
Chapter 21, page 426
Chapter 66, page 2144 Chapter 66, page 2144 Chapter 66, page 2154
Introduction
Chapter 21, page 427 Chapter 21, page 427
Multidrug-Resistant Organisms
Methicillin-Resistant Staphylococcus Aureus
Chapter 66, page 2154
Chapter 21, page 427
Vancomycin-Resistant Enterococci Chapter 66, page 2155
Chapter 21, page 430 Chapter 21, page 431 Chapter 21, page 433
Clostridioides Difficile Chapter 66, page 2154
Acinetobacter Baumannii Not covered
Carbapenem-Resistant Enterobacteriaceae (CRE)
Chapter 66, page 2155
Chapter 21, page 434
Interprofessional Management •Medical Management •Surgical Management (when applicable) •Complications •Nursing Management of Multidrug- Resistant Organisms
Chapter 66, page 2155
Chapter 21, page 434
• Medical Management • Nursing Management
Chapter 21, page 434
FADavis.com 17
Powered by FlippingBook